Skip to Content

Ajanta Pharma Ltd 532331

Morningstar Rating
INR 2,081.75 +2.05 (0.10%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

532331 is trading at a 27% premium.
Price
INR 2,086.50
Fair Value
INR 4,231.55
Uncertainty
High
1-Star Price
INR 9,948.16
5-Star Price
INR 4,896.67
Economic Moat
Jlqbnd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 532331 is a good fit for your portfolio.

Trading Information

Previous Close Price
INR 2,079.70
Day Range
INR 2,063.452,103.50
52-Week Range
INR 1,240.552,355.05
Bid/Ask
INR 0.00 / INR 0.00
Market Cap
INR 262.12 Bil
Volume/Avg
1,788 / 2,732

Key Statistics

Price/Earnings (Normalized)
35.00
Price/Sales
6.58
Dividend Yield (Trailing)
1.73%
Dividend Yield (Forward)
1.73%
Total Yield
3.21%

Company Profile

Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Growth
Total Number of Employees
7,713

Comparables

Valuation

Metric
532331
TORNTPHARM
533573
Price/Earnings (Normalized)
35.0059.5933.82
Price/Book Value
7.5212.854.24
Price/Sales
6.588.353.18
Price/Cash Flow
32.8137.3224.53
Price/Earnings
532331
TORNTPHARM
533573

Financial Strength

Metric
532331
TORNTPHARM
533573
Quick Ratio
2.060.550.72
Current Ratio
3.211.081.73
Interest Coverage
144.836.6310.47
Quick Ratio
532331
TORNTPHARM
533573

Profitability

Metric
532331
TORNTPHARM
533573
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
532331
TORNTPHARM
533573
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AFbdtnnmyNwgt$70.0 Bil
MKKGY
Merck KGaA ADRPjjfgjxdxGxxnz$68.1 Bil
HLN
Haleon PLC ADRCctsvdcgSzyzm$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRGnpxkyksYnbzk$14.3 Bil
VTRS
Viatris IncMjtskmltTsj$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRMsykbznMmwzs$11.9 Bil
CTLT
Catalent IncPkjqwqnrGtgvgbn$10.1 Bil
PRGO
Perrigo Co PLCSrdlxdrqjPtt$4.1 Bil
CURLF
Curaleaf Holdings IncNtklkzrzWpy$3.7 Bil
PBH
Prestige Consumer Healthcare IncJvnlffvfVpctnm$3.4 Bil

Sponsor Center